Glomerulosclerosis - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Glomerulosclerosis – Comprehensive Medical Guide

Glomerulosclerosis: A Comprehensive Medical Guide

Overview

Glomerulosclerosis is a pathological term that describes scarring (sclerosis) of the glomeruli – the tiny filtering units inside each kidney nephron. When glomeruli become scarred, they lose the ability to filter blood effectively, leading to protein loss, fluid retention, and progressive kidney dysfunction.

  • Who it affects: It can appear at any age, but certain forms are more common in specific populations:
    • Focal segmental glomerulosclerosis (FSGS) – most common in adults (30–50 y) and African‑American individuals.
    • Idiopathic membranous glomerulosclerosis – typical in middle‑aged men.
    • Secondary glomerulosclerosis (e.g., due to diabetes, hypertension) – prevalent in older adults.
  • Prevalence: In the United States, FSGS accounts for ~15–20 % of primary nephrotic syndrome in adults and ~30 % in children. Overall, glomerular disease contributes to roughly 10 % of end‑stage renal disease (ESRD) cases worldwide (NKF 2022).[1]

Symptoms

The presentation can be subtle early on, but as glomerular scarring progresses, classic signs of nephrotic or nephritic syndrome emerge.

Nephrotic‑type symptoms

  • Proteinuria: >3.5 g of protein per 24 h in urine; may cause frothy urine.
  • Edema: Swelling of the ankles, feet, periorbital area, or abdomen (ascites) due to fluid retention.
  • Hypoalbuminemia: Low blood albumin (<3.0 g/dL) leading to further edema.
  • Hyperlipidemia: Elevated cholesterol and triglycerides.

Nephritic‑type symptoms

  • Hematuria: Visible (gross) or microscopic blood in the urine.
  • Reduced urine output (oliguria): Less than 400 mL/day.
  • Hypertension: New‑onset or worsening high blood pressure.
  • Pain: Flank or abdominal discomfort.

General or systemic symptoms

  • Fatigue or weakness (due to anemia or toxin buildup).
  • Loss of appetite, nausea, or unexplained weight loss.
  • Frequent nighttime urination (nocturia).

Causes and Risk Factors

Glomerulosclerosis can be primary (idiopathic) or secondary to other conditions.

Primary forms

  • Focal segmental glomerulosclerosis (FSGS): May be linked to genetic mutations (e.g., NPHS2, APOL1), circulating permeability factors, or unknown immune mechanisms.
  • Membranous glomerulonephritis: Often associated with antibodies against the phospholipase A2 receptor (PLA2R).

Secondary causes

  • Diabetes mellitus: Diabetic nephropathy is the leading cause of secondary glomerulosclerosis.
  • Hypertension: Chronic pressure injury to glomeruli.
  • Obesity: Hyperfiltration injury leading to focal sclerosis.
  • Infections: HIV, hepatitis B/C, SARS‑CoV‑2.
  • Drugs & toxins: NSAIDs, certain antibiotics (e.g., penicillamine), heroin, and contrast agents.
  • Autoimmune diseases: Lupus, vasculitis.

Risk factors

  • African‑American ancestry (higher prevalence of APOL1 risk variants).
  • Family history of kidney disease.
  • Obesity (BMI > 30 kg/m²).
  • Uncontrolled hypertension or diabetes.
  • Smoking and excess alcohol intake.

Diagnosis

Diagnosing glomerulosclerosis involves a combination of clinical evaluation, laboratory tests, imaging, and most definitively, a kidney biopsy.

Initial assessment

  • Medical history & physical exam: Focus on edema, blood pressure, and any systemic disease.
  • Urinalysis: Detects proteinuria, hematuria, and casts.
  • Quantitative protein measurement: 24‑hour urine collection or spot urine protein‑to‑creatinine ratio.

Blood tests

  • Serum creatinine & estimated glomerular filtration rate (eGFR).
  • Serum albumin, lipid profile, and electrolytes.
  • Autoimmune serologies (ANA, anti‑PLA2R, complement levels) when secondary causes are suspected.

Imaging

  • Renal ultrasound: Assesses kidney size and rules out obstruction.
  • CT or MRI rarely needed unless structural anomalies are suspected.

Kidney biopsy

The gold‑standard diagnostic tool. Light microscopy shows segmental sclerosis, while immunofluorescence and electron microscopy help differentiate subtypes (FSGS vs. membranous vs. diabetic changes).

Genetic testing

Considered for early‑onset or familial cases; panels examine APOL1, NPHS1/2, and other podocyte‑related genes.

Treatment Options

Treatment aims to halt further scarring, reduce protein loss, control blood pressure, and manage underlying causes.

Medications

  • Renin‑Angiotensin‑Aldosterone System (RAAS) blockers: ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan) lower intraglomerular pressure and reduce proteinuria. Recommended target < 1 g/day proteinuria.[2]
  • Immunosuppressants (for primary forms):
    • Corticosteroids (prednisone) – first line in many FSGS protocols.
    • Calcineurin inhibitors (cyclosporine, tacrolimus) – useful when steroids fail.
    • Mycophenolate mofetil or azathioprine – adjuncts.
    • Rituximab – emerging evidence for steroid‑resistant FSGS.[3]
  • Diuretics: Loop diuretics (furosemide) for edema control.
  • Lipid‑lowering agents: Statins to treat hyperlipidemia and reduce cardiovascular risk.
  • Anticoagulation: Considered in severe nephrotic syndrome (proteinuria > 10 g/day) due to high clot risk.

Procedures

  • Plasmapheresis: May be employed in rapidly progressive or resistant forms, especially with circulating permeability factors.
  • Renal replacement therapy (RRT): Hemodialysis, peritoneal dialysis, or kidney transplantation when eGFR falls < 15 mL/min/1.73 m² or ESRD develops.

Lifestyle & supportive measures

  • Low‑sodium (<2 g/day) diet to control blood pressure and edema.
  • Moderate protein intake (0.8 g/kg/day) for those with heavy proteinuria—consult a renal dietitian.
  • Weight management and regular aerobic activity (150 min/week) to improve insulin sensitivity and blood pressure.
  • Smoking cessation and limiting alcohol.
  • Vaccinations: Hepatitis B, influenza, COVID‑19, and pneumococcal.

Living with Glomerulosclerosis

Chronic kidney disease (CKD) from glomerulosclerosis requires ongoing self‑care.

  • Regular monitoring: Blood pressure, weight, urine protein, and serum creatinine every 3–6 months (more often if unstable).
  • Medication adherence: Use pill organizers; set alarms for doses.
  • Dietary planning: Work with a renal dietitian to balance protein, sodium, potassium, and phosphorus.
  • Fluid management: Track daily intake; limit fluids only if instructed (e.g., in advanced CKD).
  • Physical activity: Low‑impact exercises such as walking, swimming, or cycling.
  • Emotional health: Join support groups; consider counseling to address anxiety or depression common with chronic illness.
  • Travel tips: Carry medication list, recent labs, and a letter from your nephrologist.

Prevention

While idiopathic forms cannot always be avoided, many risk factors are modifiable.

  • Control blood pressure: Keep <130/80 mmHg (or <140/90 mmHg per individual guidelines).
  • Maintain optimal glucose: HbA1c < 7 % for diabetics.
  • Healthy weight: BMI 18.5–24.9 kg/m².
  • Limit nephrotoxic exposures: Use NSAIDs sparingly; discuss alternative pain relievers with your doctor.
  • Screen high‑risk families: Early urinalysis and genetic counseling when there is a strong family history.
  • Vaccinate: Prevent infections that can trigger secondary glomerular disease.

Complications

If left untreated or inadequately managed, glomerulosclerosis can progress to serious complications.

  • Chronic kidney disease progression → End‑stage renal disease (ESRD): Necessitates dialysis or transplantation.
  • Thromboembolic events: Deep vein thrombosis or pulmonary embolism, especially in nephrotic syndrome.
  • Cardiovascular disease: Hypertension, dyslipidemia, and uremic toxins raise heart attack and stroke risk.
  • Infections: Loss of immunoglobulins in urine predisposes to bacterial infections.
  • Malnutrition and muscle wasting: Due to protein loss.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden shortness of breath or chest pain – possible pulmonary edema or heart attack.
  • Rapidly rising swelling of the face, lips, or throat – sign of severe fluid overload or allergic reaction to medication.
  • New onset of severe abdominal or flank pain accompanied by fever – could indicate renal infarction or infection.
  • Blood in the urine that becomes visible in large amounts (gross hematuria) combined with a drop in urine output.
  • Unexplained severe headache, vision changes, or seizures – rare but may reflect hypertensive emergency.

If you have known glomerulosclerosis, keep a list of your current medications and recent lab values handy for the care team.

References

  1. National Kidney Foundation. 2022 US Renal Data System Annual Report. nkforesight.org
  2. Mayo Clinic. “Focal segmental glomerulosclerosis (FSGS).” Updated 2023. mayoclinic.org
  3. KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int Suppl. 2023;13(2):e1‑e84.
  4. American Heart Association. “Kidney disease and cardiovascular risk.” 2022. heart.org
  5. Centers for Disease Control and Prevention. “Chronic Kidney Disease in the United States, 2021.” cdc.gov
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References